Medicare Enrolled

Dr. Eduardo Uchiyama, M.D.

Ophthalmology · Ft Lauderdale, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
6333 N FEDERAL HWY, Ft Lauderdale, FL 33308
9547766880
In practice since 2008 (18 years)
NPI: 1891973673 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Uchiyama from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Uchiyama? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Uchiyama

Dr. Eduardo Uchiyama is an ophthalmology specialist in Ft Lauderdale, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Uchiyama performed 8,850 Medicare services across 2,278 unique beneficiaries.

Between the years covered by Open Payments, Dr. Uchiyama received a total of $339,507 from 30 pharmaceutical and/or device companies across 493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Uchiyama is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 14% volume in FL $339,507 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,850
Medicare services
Top 14% in FL for ophthalmology
2,278
Unique beneficiaries
$141
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~492 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab) 3,000 $29 $100
Retinal imaging (OCT scan) 1,441 $30 $110
Aflibercept eye injection (Eylea) 968 $693 $2,400
Comprehensive eye exam, established patient 890 $90 $340
Eye injection for retinal disease 694 $97 $808
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg 598 $218 $1,082
Office visit, established patient (30-39 min) 314 $99 $350
Injection, ranibizumab, 0.1 mg 255 $184 $740
Extended exam of the back part of the eye with retinal drawing 176 $19 $150
Retinal photography (fundus photo) 146 $30 $115
New patient office visit (45-59 min) 75 $127 $500
Eye exam, established patient, focused 60 $64 $240
Office visit, established patient, complex (40-54 min) 45 $132 $500
Exam of retinal blood vessels using a special camera after injection of a dye 42 $108 $400
New patient office visit, complex (60-74 min) 42 $173 $610
Compounded drug, not otherwise classified 40 $67 $400
Comprehensive eye exam, new patient 26 $105 $400
Unclassified drugs 23 $1,921 $9,543
2d ultrasound scan of eye tissue and structures 15 $39 $159
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$339,507
Total received (2018-2024)
Avg $48,501/year across 7 years
Top 2% in FL for ophthalmology
30
Companies
493
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$272,169 (80.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$59,689 (17.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,649 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$41,278
2023
$62,274
2022
$82,665
2021
$30,700
2020
$39,892
2019
$48,770
2018
$33,928

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$102,108
Apellis Pharmaceuticals, Inc.
$59,698
Novartis Pharmaceuticals Corporation
$52,780
AbbVie, Inc.
$29,853
Bausch & Lomb Americas Inc.
$27,869
EyePoint Pharmaceuticals US, Inc.
$22,147
Alimera Sciences, Inc.
$15,351
Regeneron Pharmaceuticals, Inc.
$5,715
GlaxoSmithKline, LLC.
$4,820
Bausch & Lomb, a division of Bausch Health US, LLC
$4,056
Genentech USA, Inc.
$3,505
Genentech, Inc.
$3,442
Astellas Pharma US Inc
$2,362
Allergan, Inc.
$2,291
Allergan Inc.
$841
ANI Pharmaceuticals, Inc.
$663
Mallinckrodt Hospital Products Inc.
$382
ABBVIE INC.
$322
Alcon Laboratories Inc
$227
Coherus Biosciences Inc.
$178
Alcon Vision LLC
$151
Mallinckrodt Enterprises LLC
$144
Dutch Ophthalmic, USA
$143
AbbVie Inc.
$125
Aerie Pharmaceuticals, Inc.
$100
Mallinckrodt LLC
$92
Sandoz Inc.
$76
Astellas Pharma Global Development
$30
Kala Pharmaceuticals, Inc.
$20
Harrow Eye, LLC
$17
Top 3 companies account for 63.2% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · BEOVU · BLENREP · BROLUCIZUMAB · BUPARLISIB · Cimerli · Clareon · Constellation · DEXYCU · EVA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · IHEEZO · ILEVRO · ILUVIEN · INVELTYS · Iluvien · Izervay · Lucentis · Non-Covered Product · OZURDEX · PURIFIED CORTROPHIN GEL · SUSVIMO · Syfovre · VABYSMO · VYZULTA · Vabysmo · XEN GLAUCOMA TREATMENT SYSTEM · XIPERE · YUTIQ · combined machine · rhopressa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for ophthalmology in FL.

Equivalent to $3,836 per 100 Medicare services performed
Looking for an ophthalmology specialist in Ft Lauderdale?
Compare ophthalmologists in the Ft Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
244
Per 100K population
12.5
County median income
$74,534
Nearest hospital
HOLY CROSS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Uchiyama is a mixed practice specialist, with above-average Medicare volume (top 14% in FL), with speaking/promotional industry engagement in the top 2% of FL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Uchiyama experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Uchiyama performed 3,000 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Uchiyama receive payments from pharmaceutical companies?
Yes. Dr. Uchiyama received a total of $339,507 from 30 companies across 493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Uchiyama's costs compare to other ophthalmologists in Ft Lauderdale?
Dr. Uchiyama's average Medicare payment per service is $141. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Uchiyama) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →